获取电话| MM0018.06 | 盐酸环丙沙星单水合物 | 500mg | 12953 | Ciprofloxacin Hydrochloride Monohydrate | 含量测定 |
| MM0019.00 | 左美丙嗪马来酸 | 100mg | 12953 | Levomepromazine Maleate | 含量测定 |
| MM0019.01 | 左美丙嗪马来酸杂质B | 100mg | 12953 | Levomepromazine Maleate Imp. B (EP): 10-[(2R)-3-(Dimethylamino)-2-methylpropyl]-2-methoxy-10H-phenothiazine 5-Oxide (Levomepromazine S-Oxide) | 含量测定 |
| MM0019.02 | 左美丙嗪马来酸杂质A | 100mg | 12953 | Levomepromazine Maleate Imp. A (EP): 2-Methoxyphenothiazine | 含量测定 |
| MM0020.00 | 西米替丁 | 500mg | 12953 | Cimetidine | 含量测定 |
| MM0020.03 | 西米替丁杂质C | 100mg | 12953 | Cimetidine Hydrochloride Imp. C (EP) as Dihydrochloride: 1-[(Methylamino)[[2-[[(5-methyl-1H-imidazol-4-yl)-methyl]sulphanyl]ethyl]amino]methylene]urea Dihydrochloride (Cimetidine Amide Dihydrochloride) | 含量测定 |
| MM0020.04 | 西米替丁杂质E | 100mg | 12953 | Cimetidine Hydrochloride Imp. E (EP): 2-Cyano-1-methyl-3-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphinyl]ethyl]guanidine(Cimetidine Sulphoxide) | 含量测定 |
| MM0020.06 | 西米替丁杂质D | 100mg | 12953 | Cimetidine Hydrochloride Imp. D (EP) as Dihydrochloride:1-Methyl-3-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]guanidineDihydrochloride | 含量测定 |
| MM0020.07 | 西米替丁杂质H | 100mg | 12953 | Cimetidine Hydrochloride Imp. H (Pharmeuropa): 1,1'-(Disulphanediyldiethylene)bis(2-cyano-3-methylguanidine) | 含量测定 |
| MM0020.08 | 西米替丁杂质A | 100mg | 12953 | Cimetidine Hydrochloride Imp. A (EP): 3-Cyano-2-methyl-1-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]-sulphanyl]ethyl]isothiourea | 含量测定 |
| MM0020.12 | 西米替丁杂质B | 100mg | 12953 | Cimetidine Hydrochloride Imp. B (EP): 3-Cyano-2-methyl-1-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]-sulphanyl]ethyl]isourea | 含量测定 |
| MM0020.15 | 西米替丁杂质G | 100mg | 12953 | Cimetidine Hydrochloride Imp. G (Pharmeuropa): 2-Cyano-1,3-dimethylguanidine | 含量测定 |
| MM0020.50 | 西米替丁杂质J | 100mg | 12953 | Cimetidine Hydrochloride Imp. J (Pharmeuropa) as Dihydrobromide: 2-[[(5-Methyl-1H-imidazol-4-yl)methyl]-sulphanyl]ethanamine Dihydrobromide | 含量测定 |
| MM0021.00 | 维生素B6 | 500mg | 12953 | Pyridoxine Hydrochloride | 含量测定 |
| MM0021.01 | 维生素B7杂质A | 100mg | 26235 | Pyridoxine Hydrochloride Imp. A (EP) as Hydrochloride: 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-olHydrochloride | 含量测定 |
| MM0021.02 | 维生素B8杂质B | 100mg | 12953 | Pyridoxine Hydrochloride Imp. B (EP) as Hydrochloride: 5-(Hydroxymethyl)-2,4-dimethylpyridin-3-ol Hydrochloride | 含量测定 |
| MM0021.03 | 吡哆辛乙酯 | 100mg | 12953 | Pyridoxine Diacetate | 含量测定 |
| MM0021.05 | 盐酸吡哆醛 | 100mg | 12953 | Pyridoxal Hydrochloride | 含量测定 |
| MM0021.06 | 盐酸吡多胺 | 100mg | 12953 | Pyridoxamine Dihydrochloride | 含量测定 |
| MM0021.07 | 4-吡哆酸 | 50mg | 26235 | 4-Pyridoxic Acid | 含量测定 |
| MM0022.00 | 维拉帕米盐酸盐 | 500mg | 12953 | Verapamil Hydrochloride | 含量测定 |
| MM0022.02 | 维拉帕米盐酸盐杂质D | 100mg | 12953 | Verapamil Hydrochloride Imp. D (EP): 3-Chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methylpropan-1-amine | 含量测定 |
| MM0022.03 | 维拉帕米盐酸盐杂质K | 100mg | 12953 | Verapamil Hydrochloride Imp. K (EP): (2RS)-2-(3,4-Dimethoxyphenyl)-3-methylbutylnitrile | 含量测定 |
| MM0022.04 | 维拉帕米盐酸盐杂质G | 100mg | 4950 | Verapamil Hydrochloride Imp. G (EP): 3,4-Dimethoxybenzaldehyde | 含量测定 |
| MM0022.05 | 维拉帕米盐酸盐杂质E | 100mg | 4950 | Verapamil Hydrochloride Imp. E (EP): (3,4-Dimethoxyphenyl)methanol | 含量测定 |
| MM0022.07 | 维拉帕米盐酸盐杂质A | 100mg | 12953 | Verapamil Hydrochloride Imp. A (EP) as Dihydrochloride: N,N'-Bis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethylpropane-1,3-diamine Dihydrochloride | 含量测定 |
| MM0022.08 | 维拉帕米盐酸盐杂质B | 100mg | 12953 | Verapamil Hydrochloride Imp. B (EP) as Hydrochloride: 2-(3,4-Dimethoxyphenyl)-N-methylethanamineHydrochloride | 含量测定 |
| MM0022.09 | 维拉帕米盐酸盐杂质C | 100mg | 12953 | Verapamil Hydrochloride Imp. C (EP) as Hydrochloride: 2-(3,4-Dimethoxyphenyl)-N,N-dimethylethan-amine Hydrochloride | 含量测定 |
| MM0022.10 | 维拉帕米盐酸盐杂质F | 100mg | 12953 | Verapamil Hydrochloride Imp. F (EP) as Hydrochloride: (2RS)-2-(3,4-Dimethoxyphenyl)-5-(methylamino)-2-(1-methylethyl)pentanenitrile Hydrochloride | 含量测定 |
| MM0022.11 | 维拉帕米盐酸盐杂质H | 100mg | 12953 | Verapamil Hydrochloride Imp. H (EP) as Hydrochloride: (2RS)-2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)-ethyl](methyl)amino]-2-ethylpentanenitrile Hydrochloride | 含量测定 |
| MM0022.13 | 维拉帕米盐酸盐杂质L | 100mg | 12953 | Verapamil Hydrochloride Imp. L (EP): 1-(3,4-Dimethoxyphenyl)-2-methylpropan-1-one | 含量测定 |
| MM0022.16 | 维拉帕米盐酸盐杂质O | 100mg | 12953 | Verapamil Hydrochloride Imp. O (EP) as Hydrochloride: (2RS)-2-(3,4-Dimethoxyphenyl)-5-[2-[2-(3,4-dimethoxy-phenyl)ethyl](methyl)amino]- 2-propylpentane-nitrile Hydrochloride | 含量测定 |
| MM0022.19 | 维拉帕米氮氧化物盐酸盐 | 50mg | 6105 | Verapamil N-Oxide Hydrochloride | 含量测定 |
| MM0022.21 | 维拉帕米盐酸盐杂质J | 100mg | 12953 | Verapamil Hydrochloride Imp. J (EP) as Maleate: (2RS)- | 含量测定 |
| MM0023.00 | 地西泮 | 100mg | 12953 | Diazepam [Controlled Substance] | 含量测定 |
| MM0023.03 | 地西泮杂质C | 100mg | 12953 | Diazepam Imp. C (EP): 3-Amino-6-chloro-1-methyl-4-phenylquinolin-2(1H)-one | 含量测定 |
| MM0023.04 | 地西泮杂质B | 100mg | 12953 | Diazepam Imp. B (EP): 2-Chloro-N-(4-chloro-2-benzoylphenyl)-N-methylacetamide | 含量测定 |
| MM0024.00 | 乙酰半胱氨酸 | 500mg | 12953 | N-Acetyl-L-cysteine | 含量测定 |
| MM0024.01 | 乙酰半胱氨酸杂质D | 100mg | 12953 | Acetylcysteine Imp. D (EP): N,S-Diacetyl-L-cysteine | 含量测定 |
| MM0024.02 | 乙酰半胱氨酸杂质B | 100mg | 4950 | Acetylcysteine Imp. B (EP): L-Cysteine | 含量测定 |
| MM0024.03 | 乙酰半胱氨酸杂质A | 100mg | 4950 | Acetylcysteine Imp. A (EP): L-Cystine | 含量测定 |
| MM0024.04 | 乙酰半胱氨酸杂质C | 100mg | 12953 | Acetylcysteine Imp. C (EP): N,N'-Diacetyl-L-cystine | 含量测定 |
| MM0025.00 | 苯丁哌胺盐酸盐 | 500mg | 12953 | Loperamide Hydrochloride | 含量测定 |
| MM0025.04 | 苯丁哌胺盐酸盐杂质C | 100mg | 4950 | Loperamide Hydrochloride Imp. C (EP): 4-(4-Chlorophenyl)piperidin-4-ol | 含量测定 |
| MM0025.05 | 苯丁哌胺盐酸盐杂质D | 100mg | 12953 | Loperamide Hydrochloride Imp. D (EP): 4-(4-Hydroxy-4-phenylpiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide | 含量测定 |
| MM0025.07 | 二苯基乙酸乙酯 | 100mg | 12953 | Ethyl Diphenylacetate | 含量测定 |
| MM0025.09 | 苯丁哌胺盐酸盐杂质F | 100mg | 12953 | Loperamide Hydrochloride Imp. F (EP): Loperamide Oxide | 含量测定 |
| MM0025.11 | 苯丁哌胺盐酸盐杂质H | 100mg | 12953 | Loperamide Hydrochloride Imp. H (EP): 4-[4-(4-Chlorophenyl)-3,6-dihydropyridin-1(2H)-yl]-N,N-dimethyl-2,2-diphenylbutanamide | 含量测定 |
| MM0025.15 | 苯丁哌胺盐酸盐杂质B | 100mg | 12953 | Loperamide Hydrochloride Imp. B (EP) as Bromide: 4-(4-Chlorophenyl)-1,1-bis[4-(dimethylamino)-4-oxo-3,3-diphenyl-butyl]-4-hydroxypiperidinium Bromide | 含量测定 |
| MM0026.00 | 青霉素V钾 | 250mg | 12953 | Phenoxymethylpenicillin Potassium | 含量测定 |
| MM0026.01 | 青霉素V钾杂质E | 100mg | 12953 | Phenoxymethylpenicillin Potassium Imp. E (EP): (4S)-2-[Carboxy[(phenoxyacetyl)amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic Acid (Penicilloic Acids of Phenoxymethylpenicillin) | 含量测定 |
| MM0026.02 | 青霉素V钾杂质D | 100mg | 12953 | Phenoxymethylpenicillin Potassium Imp. D (EP): (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[[2-(4-hydroxyphenoxy)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicAcid (4-Hydroxyphenoxymethylpenicillin) | 含量测定 |
| MM0026.03 | 青霉素V钾杂质B | 100mg | 4950 | Phenoxymethylpenicillin Potassium Imp. B (EP): Phenoxyacetic Acid | 含量测定 |
| MM0026.04 | 6-氨基青酶烷酸 | 100mg | 4950 | (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid(6-Aminopenicillanic Acid) | 含量测定 |
| MM0026.05 | 青霉素V钾杂质F | 100mg | 12953 | Phenoxymethylpenicillin Potassium Imp. F (EP): (2RS,4S)-5,5-Dimethyl-2-[[(phenoxyacetyl)amino]methyl]thiazolidine-4-carboxylic Acid (Penilloic Acids of Phenoxymethylpenicillin) | 含量测定 |
| MM0027.00 | 酒石酸美托洛尔 | 500mg | 12953 | Metoprolol Tartrate | 含量测定 |
| MM0028.02 | 氯氮卓盐酸盐杂质A | 100mg | 12953 | Chlordiazepoxide Hydrochloride Imp. A (EP): 7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-Oxide(Demoxepam) | 含量测定 |
| MM0028.04 | 氯氮卓盐酸盐杂质B | 100mg | 12953 | Chlordiazepoxide Hydrochloride Imp. B (EP): 6-Chloro-2-(chloromethyl)-4-phenylquinazoline 3-Oxide | 含量测定 |
| MM0028.08 | 氯氮卓 | 100mg | 12953 | Chlordiazepoxide [Controlled Substance] | 含量测定 |
| MM0029.00 | 法莫替丁 | 250mg | 12953 | Famotidine | 含量测定 |
| MM0029.01 | 法莫替丁杂质C | 100mg | 12953 | Famotidine Imp. C (EP): 3-(2-Diaminomethylenamino-1,3-thiazol-4-ylmethyl-sulphanyl)-N-sulphamoylpropanamide | 含量测定 |
| MM0029.02 | 法莫替丁杂质D | 100mg | 12953 | Famotidine Imp. D (EP): 3-[[[2-[(Diaminomethylene)-amino]thiazol-4-yl]methyl]sulphanyl]propanamide | 含量测定 |
| MM0029.03 | 法莫替丁杂质F | 100mg | 12953 | Famotidine Imp. F (EP): 3-[[[2-[(Diaminomethylene)-amino]thiazol-4-yl]methyl]sulphanyl]propanoic Acid | 含量测定 |
标准物质 盐酸环丙沙星单水合物由东莞康润实验科技有限公司为您提供，如想了解更多关于临床与卫生标准物质/标准品 盐酸环丙沙星单水合物的报价、规格、厂家等信息，欢迎来电或留言咨询。除供应盐酸环丙沙星单水合物外，东莞康润实验科技有限公司还可为您提供：
ERM-EC681M 低密度聚乙烯标准物质(high level)、
LabGenius 二氯甲烷 HPLC/农残级 4L ≥99.9%、
10种PBDE多溴联苯醚混标 S-15497-10X
